CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
CVRx (NASDAQ: CVRX), a commercial-stage medical device company, has scheduled the release of its first quarter 2025 financial and operating results after market close on Thursday, May 8, 2025. The company will host a conference call and live webcast at 4:30pm Eastern Time to discuss the results.
Investors can access the webcast through the company's investor relations website at ir.cvrx.com. For telephone participation, U.S. callers should dial 1-800-445-7795, while international callers can use 1-785-424-1699. The conference ID for the call is CVRXQ125.
CVRx (NASDAQ: CVRX), un'azienda di dispositivi medici in fase commerciale, ha programmato la pubblicazione dei risultati finanziari e operativi del primo trimestre 2025 dopo la chiusura del mercato di giovedì 8 maggio 2025. La società terrà una conference call e una diretta web alle 16:30 ora della costa orientale per discutere i risultati.
Gli investitori potranno seguire la diretta web tramite il sito web delle relazioni con gli investitori all'indirizzo ir.cvrx.com. Per partecipare telefonicamente, i chiamanti dagli Stati Uniti devono comporre il numero 1-800-445-7795, mentre i chiamanti internazionali possono utilizzare il numero 1-785-424-1699. Il codice identificativo della conference call è CVRXQ125.
CVRx (NASDAQ: CVRX), una empresa de dispositivos médicos en etapa comercial, ha programado la publicación de sus resultados financieros y operativos del primer trimestre de 2025 después del cierre del mercado el jueves 8 de mayo de 2025. La compañía realizará una llamada conferencia y una transmisión en vivo a las 4:30 pm hora del Este para analizar los resultados.
Los inversionistas pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de la empresa en ir.cvrx.com. Para participar por teléfono, los llamantes desde EE. UU. deben marcar 1-800-445-7795, mientras que los llamantes internacionales pueden usar 1-785-424-1699. El ID de la conferencia es CVRXQ125.
CVRx (NASDAQ: CVRX)는 상업 단계 의료기기 회사로서 2025년 1분기 재무 및 운영 실적을 2025년 5월 8일 목요일 시장 마감 후에 발표할 예정입니다. 회사는 결과를 논의하기 위해 동부 표준시 오후 4시 30분에 컨퍼런스 콜과 라이브 웹캐스트를 진행합니다.
투자자들은 회사의 투자자 관계 웹사이트 ir.cvrx.com을 통해 웹캐스트에 접속할 수 있습니다. 전화 참여를 원할 경우 미국 내 발신자는 1-800-445-7795번으로, 국제 발신자는 1-785-424-1699번으로 전화하면 됩니다. 컨퍼런스 콜 ID는 CVRXQ125입니다.
CVRx (NASDAQ : CVRX), une entreprise de dispositifs médicaux en phase commerciale, a prévu la publication de ses résultats financiers et opérationnels du premier trimestre 2025 après la clôture des marchés le jeudi 8 mai 2025. La société organisera une conférence téléphonique et une diffusion en direct à 16h30 heure de l'Est pour discuter des résultats.
Les investisseurs peuvent accéder à la diffusion en direct via le site web des relations investisseurs de l'entreprise à ir.cvrx.com. Pour participer par téléphone, les appelants américains doivent composer le 1-800-445-7795, tandis que les appelants internationaux peuvent utiliser le 1-785-424-1699. L'ID de la conférence est CVRXQ125.
CVRx (NASDAQ: CVRX), ein medizinisches Geräteunternehmen in der kommerziellen Phase, hat die Veröffentlichung seiner finanziellen und operativen Ergebnisse für das erste Quartal 2025 nach Börsenschluss am Donnerstag, den 8. Mai 2025 geplant. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Live-Webcast abhalten, um die Ergebnisse zu besprechen.
Investoren können den Webcast über die Investor-Relations-Website des Unternehmens unter ir.cvrx.com verfolgen. Für die telefonische Teilnahme wählen Anrufer aus den USA die Nummer 1-800-445-7795, internationale Anrufer verwenden 1-785-424-1699. Die Konferenz-ID für den Anruf lautet CVRXQ125.
- None.
- None.
MINNEAPOLIS, April 24, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that it plans to release first quarter 2025 financial and operating results after market close on Thursday, May 8, 2025. The Company will host a conference call to review its results at 4:30pm Eastern Time the same day.
A live webcast of the investor conference call will be available online at the investor relations page of the Company’s website at ir.cvrx.com. To listen to the conference call on your telephone, please dial 1-800-445-7795 for U.S. callers, or 1-785-424-1699 for international callers, approximately ten minutes prior to the start time. Please reference the following conference ID to access the call: CVRXQ125.
About CVRx, Inc.
CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has also received the CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.
Investor Contact:
Mark Klausner or Mike Vallie
ICR Westwicke
443-213-0501
ir@cvrx.com
Media Contact:
Emily Meyers
CVRx, Inc.
763-416-2853
emeyers@cvrx.com
FAQ
When will CVRx (CVRX) release Q1 2025 earnings?
How can I join the CVRx (CVRX) Q1 2025 earnings call?
What time is the CVRx (CVRX) earnings call on May 8, 2025?
Where can I find CVRx (CVRX) Q1 2025 earnings webcast?
